Vedove, D., Cazzanelli, G., D’Agostino, V. G., Vargas-Rosales, P. A., Caflisch, A., & Lolli, G. (2026). Unusual Backfolded Binding Poses of BAZ2A Bromodomain Binders. Acta Crystallographica Section D, Structural Biology, 82(7), 1-9. https://doi.org/10.1107/S2059798326004596 (Original work published)

Cazzanelli, G., Vedove, D., Sbardellati, N., Valer, L., Caflisch, A., & Lolli, G. (2024). Enhanced cellular death in liver and breast cancer cells by dual BET/BRPF1 inhibitors. Protein Science, 33(11), e5191. https://doi.org/10.1002/pro.5191 (Original work published)

Vedove, D., Cazzanelli, G., Corsi, J., Sedykh, M., Batiste, L., Marchand, J.-R., … Lolli, G. (2023). Identification of BAZ2A bromodomain hit compounds. Acta Crystallographica Section A: Foundations of Crystallography, 78(X), a418-a418. https://doi.org/10.1107/S2053273322093214 (Original work published)

Cazzanelli, G., Vedove, A., Parolin, E., D’Agostino, V., Unzue, A., Nevado, C., … Lolli, G. (2023). Reevaluation of bromodomain ligands targeting BAZ2A. Protein Science, 32(9), e4752. https://doi.org/10.1002/pro.4752 (Original work published)

Dalle Vedove, A., Cazzanelli, G., Batiste, L., Marchand, J.-R., Spiliotopoulos, D., Corsi, J., … Lolli, G. (2022). Identification of a BAZ2A-bromodomain hit compound by fragment growing. ACS Medicinal Chemistry Letters, 13(9), 1434-1443. https://doi.org/10.1021/acsmedchemlett.2c00173

Dalle Vedove, A., Cazzanelli, G., Corsi, J., Sedykh, M., D’Agostino, V. G., Caflisch, A., & Lolli, G. (2021). Identification of a BAZ2A bromodomain hit compound by fragment joining. ACS Bio & Med Chem Au, 1(1), 5-10. https://doi.org/10.1021/acsbiomedchemau.1c00016

Dalle Vedove, A., Spiliotopoulos, D., D’Agostino, V. G., Marchand, J.-R., Unzue, A., Nevado, C., … Caflisch, A. (2018). Structural analysis of small molecule binding to the BAZ2A and BAZ2B bromodomains. ChemMedChem, 13(14), 1479-1487. https://doi.org/10.1002/cmdc.201800234 (Original work published)

Marchand, J.-R., Dalle Vedove, A., Lolli, G., & Caflisch, A. (2017). Discovery of inhibitors of four bromodomains by fragment-anchored ligand docking. Journal of Chemical Information and Modeling, 57(10), 2584-2597. https://doi.org/10.1021/acs.jcim.7b00336 (Original work published)

Spiliotopoulos, D., Wamhoff, E.-C., Lolli, G., Rademacher, C., & Caflisch, A. (2017). Discovery of BAZ2A bromodomain ligands. European Journal of Medicinal Chemistry, 139, 564-572. https://doi.org/10.1016/j.ejmech.2017.08.028 (Original work published)

Marchand, J.-R., Lolli, G., & Caflisch, A. (2016). Derivatives of 3-amino-2-methylpyridine as BAZ2B bromodomain ligands: In silico discovery and in crystallo validation. Journal of Medicinal Chemistry, 59(21), 9919-9927. https://doi.org/10.1021/acs.jmedchem.6b01258 (Original work published)